業績

主要論文 2015年

  1. Fujiwara T, Harigae H.
    【Update on the biology of heme synthesis in erythroid cells】.
    Rinsho Ketsueki. 2015 Feb;56(2):119-27. doi: 10.11406/rinketsu.56.119. Japanese.
  2. Nakaseko C, Takahashi N, Ishizawa K, Kobayashi Y, Ohashi K, Nakagawa Y, Yamamoto K, Miyamura K, Taniwaki M, Okada M, Kawaguchi T, Shibata A, Fujii Y, Ono C, Ohnishi K.
    A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia.
    Int J Hematol. 2015 Feb;101(2):154-64. doi: 10.1007/s12185-014-1722-8.  Epub 2014 Dec 25.
  3. Narumi K, Hirose T, Sato E, Mori T, Kisu K, Ishikawa M, Totsune K, Ishii T, Ichihara A, Nguyen G, Sato H, Ito S.
    A functional (pro)renin receptor is expressed in human lymphocytes and monocytes.
    Am J Physiol Renal Physiol. 2015 Mar 1;308(5):F487-99. doi: 10.1152/ajprenal.00206.2014. Epub 2014 Dec 10.
  4. Harigae H.
    [Programs for Continuing Medical Education: B session; 7. Diagnosis and treatment of anemia].
    Nihon Naika Gakkai Zasshi. 2015 Mar 10;104(3):567-71. Japanese.
  5. Ichikawa S, Ichikawa S, Ishikawa I, Takahashi T, Fujiwara T, Harigae H.
    Successful treatment of acute promyelocytic leukemia with a t(X;17) (p11.4;q21) and BCOR-RARA fusion gene.
    Cancer Genet. 2015 Apr;208(4):162-3. doi: 10.1016/j.cancergen.2015.01.008. Epub 2015 Feb 2.
  6. Wang J1, Shirota Y1, Bayik D1, Shirota H1, Tross D1, Gulley JL2, Wood LV3, Berzofsky JA3, Klinman DM4.
    Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells.
    J Immunol. 2015 May 1;194(9):4215-21. doi: 10.4049/jimmunol.1402004. Epub 2015 Mar 30.
  7. Hirokawa M, Sawada K, Fujishima N, Teramura M, Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Fujisawa S, Yonemura Y, Kawano F, Oshimi K, Sugimoto K, Matsuda A, Karasawa M, Arai A, Komatsu N, Harigae H, Omine M, Ozawa K, Kurokawa M; PRCA Collaborative Study Group.
    Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
    Br J Haematol. 2015 Jun;169(6):879-86. doi: 10.1111/bjh.13376. Epub 2015 Mar 25.
  8. Kameoka Y, Takahashi N, Itou S, Kume M, Noji H, Kato Y, Ichikawa Y, Sasaki O, Motegi M, Ishiguro A, Tagawa H, Ishizawa K, Ishida Y, Ichinohasama R, Harigae H, Sawada K.
    Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma.
    Int J Hematol. 2015 Jun;101(6):536-42. doi: 10.1007/s12185-015-1763-7. Epub 2015 Mar 5.
  9. Inui M, Hirota S, Hirano K, Fujii H, Sugahara-Tobinai A, Ishii T, Harigae H, Takai T.
    Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasma blasts developmentally in healthy individuals.
    Int Immunol. 2015 Jul;27(7):345-55. doi: 10.1093/intimm/dxv009. Epub 2015 Mar 5. 
  10. Watanabe R, Ishii T, Yoshida M, Takada N, Yokokura S, Shirota Y, Fujii H, Harigae H.
    Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review.
    Int J Rheum Dis. 2015 Jul 14. doi: 10.1111/1756-185X.12688. [Epub ahead of print]
  11. Harigae H.
    [Anemia: From Basic Knowledge to Up-to-Date Treatment. Topic: III. Iron metabolism and iron deficiency anemia--Recent findings].
    Nihon Naika Gakkai Zasshi. 2015 Jul 10;104(7):1383-8. Japanese.
  12. Saito Y, Fujiwara T, Ohashi K, Okitsu Y, Fukuhara N, Onishi Y, Ishizawa K, Harigae H.
    High-Throughput siRNA Screening to Reveal GATA-2 Upstream Transcriptional Mechanisms in Hematopoietic Cells.
    PLoS One. 2015 Sep 1;10(9):e0137079. doi: 10.1371/journal.pone.0137079. eCollection 2015.
  13. Takada N, Watanabe R, Fujii H, Kamogawa Y, Fujita Y, Shirota Y, Saito S, Ishii T, Harigae H.
    Pseudothrombocytosis caused by cryoglobulin crystals in a patient with primary Sjögren's syndrome.
    Mod Rheumatol. 2015 Sep;25(5):814-5. doi: 10.3109/14397595.2014.926851. Epub 2015 Jul 29.
  14. Maeda N, Ohashi T, Chagan-Yasutan H, Hattori T, Takahashi Y, Harigae H, Hasegawa H, Yamada Y, Fujii M, Maenaka K, Uede T.
    Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.
    Retrovirology. 2015 Nov 24;12:99. doi: 10.1186/s12977-015-0225-x.
  15. Murai K, Akagi T, Shimosegawa K, Sugawara T, Ishizawa K, Ito S, Murai K, Motegi M, Yokoyama H, Noji H, Tajima K, Kimura J, Chou T, Ogawa K, Harigae H, Kubo K, Oba K, Sakamoto J, Ishida Y.
    A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria.
    Eur J Haematol. 2015 Dec;95(6):558-65. doi: 10.1111/ejh.12536. Epub 2015 Mar 25.    
  16. Tomiyama F, Watanabe R, Fujii H, Kamogawa Y, Fujita Y, Shirota Y, Nakamichi T, Sato H, Ishii T, Harigae H.
    Synovitis in a Patient with IgG4-related Disease.
    Intern Med. 2015;54(11):1427-32. doi: 10.2169/internalmedicine.54.4320. Epub 2015 Jun 1.
  17. Fujiwara T, Harigae H.
    Biology of Heme in Mammalian Erythroid Cells and Related Disorders.
    Biomed Res Int. 2015;2015:278536. doi: 10.1155/2015/278536. Epub 2015 Oct 18
  18. Watanabe R, Ishii T, Harigae H.
    Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus.
    Tohoku J Exp Med. 2015;237(1):9-15. doi: 10.1620/tjem.237.9.
  19. Watanabe R, Fujii H, Kamogawa Y, Nakamura K, Shirai T, Ishii T, Harigae H.
    Chronic lupus peritonitis is characterized by the ascites with a large content of interleukin-6.
    Tohoku J Exp Med. 2015;235(4):289-94. doi: 10.1620/tjem.235.289.